Delhi LG recommends CBI probe into alleged supply of ‘non-standard’ drugs in govt hospitals

New Delhi, Dec 23 (UNI) Delhi Lieutenant Governor VK Saxena on Saturday recommended a CBI inquiry into the alleged procurement and supply of “non-standard drugs” in the city’s government hospitals and Mohalla Clinics.

A statement from the LG office said after complaints from several patients and people at large, samples were collected from three major Hospitals – IHBAS, Lok Nayak and Deen Dayal Upadhyay that cater to lakhs of patients.

“Accordingly, since the matter of Mohalla Clinics is already entrusted to CBI, this case, which may, inter alia, also involve supply of these failed “Not of Standard Quality” drugs to such clinics, may also be entrusted to the Central Agency, especially in light of the fact that the investigation therein involves multi inter-state stakeholders,” the statement said.

The move comes after, the Drug Controller under Health Department, GNCTD, on the basis of complaints regarding alleged sub-standard medicines being supplied in Delhi government hospitals, randomly collected the drug samples from three hospitals and sent them to the approved government and private labs for testing.

The reports of the labs were sent by the Drug Controller and the Department of Health for further necessary action to the Directorate of Vigilance (DoV). The DoV, based on test reports, found that more than 10 percent of the drug/medicine samples failed and were found to be “Not of standard quality”.

According to the Vigilance department, out of 43 samples that were sent to government labs, 3 samples failed the test and 12 reports are still pending. Further, out of another 43 samples sent to private labs, 5 samples failed, the statement added.

Leave a Reply